Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary

NEW YORK (GenomeWeb) – Eurofins Genomics today announced the acquisition of VBC-Biotech's oligonucleotide synthesis and DNA sequencing businesses and the establishment of an Austrian subsidiary.

Eurofins Genomics is the genomics division of the Eurofins Scientific Group. The Austrian subsidiary, called Eurofins Genomics AT and headquartered in Vienna, will leverage Eurofins' global network, production capacity, and infrastructure.

"The new direct presence in Austria will provide value to our customers by demonstration our commitment to this market," Eurofins Genomics AT Managing Director Siegfried Schnabl said in a statement. "Furthermore, Vienna will serve as a perfect hub for future business into Central and Eastern Europe and beyond."

Financial and other terms of the deal were not disclosed.

Earlier this month, Eurofins Genomics established a subsidiary in Milan, Italy by buying the oligonucleotide and DNA sequencing business of Primm.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.